{
  "DOI": "10.1007/s00439-019-02081-x",
  "ISSN": [
    "0340-6717",
    "1432-1203"
  ],
  "URL": "http://dx.doi.org/10.1007/s00439-019-02081-x",
  "abstract": "\u003cjats:title\u003eAbstract\u003c/jats:title\u003e\n\u003cjats:p\u003eThe human solute carrier (\u003cjats:italic\u003eSLC\u003c/jats:italic\u003e) superfamily of transporters is comprised of over 400 membrane-bound proteins, and plays essential roles in a multitude of physiological and pharmacological processes. In addition, perturbation of SLC transporter function underlies numerous human diseases, which renders SLC transporters attractive drug targets. Common genetic polymorphisms in \u003cjats:italic\u003eSLC\u003c/jats:italic\u003e genes have been associated with inter-individual differences in drug efficacy and toxicity. However, despite their tremendous clinical relevance, epidemiological data of these variants are mostly derived from heterogeneous cohorts of small sample size and the genetic \u003cjats:italic\u003eSLC\u003c/jats:italic\u003e landscape beyond these common variants has not been comprehensively assessed. In this study, we analyzed Next-Generation Sequencing data from 141,456 individuals from seven major human populations to evaluate genetic variability, its functional consequences, and ethnogeographic patterns across the entire \u003cjats:italic\u003eSLC\u003c/jats:italic\u003e superfamily of transporters. Importantly, of the 204,287 exonic single-nucleotide variants (SNVs) which we identified, 99.8% were present in less than 1% of analyzed alleles. Comprehensive computational analyses using 13 partially orthogonal algorithms that predict the functional impact of genetic variations based on sequence information, evolutionary conservation, structural considerations, and functional genomics data revealed that each individual genome harbors 29.7 variants with putative functional effects, of which rare variants account for 18%. Inter-ethnic variability was found to be extensive, and 83% of deleterious SLC variants were only identified in a single population. Interestingly, population-specific carrier frequencies of loss-of-function variants in \u003cjats:italic\u003eSLC\u003c/jats:italic\u003e genes associated with recessive Mendelian disease recapitulated the ethnogeographic variation of the corresponding disorders, including cystinuria in Jewish individuals, type II citrullinemia in East Asians, and lysinuric protein intolerance in Finns, thus providing a powerful resource for clinical geneticists to inform about population-specific prevalence and allelic composition of Mendelian \u003cjats:italic\u003eSLC\u003c/jats:italic\u003e diseases. In summary, we present the most comprehensive data set of \u003cjats:italic\u003eSLC\u003c/jats:italic\u003e variability published to date, which can provide insights into inter-individual differences in SLC transporter function and guide the optimization of population-specific genotyping strategies in the bourgeoning fields of personalized medicine and precision public health.\u003c/jats:p\u003e",
  "alternative-id": [
    "2081"
  ],
  "assertion": [
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Received",
      "name": "received",
      "order": 1,
      "value": "4 August 2019"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Accepted",
      "name": "accepted",
      "order": 2,
      "value": "26 October 2019"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "First Online",
      "name": "first_online",
      "order": 3,
      "value": "2 November 2019"
    },
    {
      "group": {
        "label": "Compliance with ethical standards",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 1
    },
    {
      "group": {
        "label": "Conflict of interest",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 2,
      "value": "VML is co-founder and owner of HepaPredict AB. LS has no conflicts of interest to declare."
    }
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Schaller",
      "given": "Lena",
      "sequence": "first"
    },
    {
      "ORCID": "http://orcid.org/0000-0002-1140-6204",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Lauschke",
      "given": "Volker M.",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Human Genetics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2019,
        11,
        2
      ]
    ],
    "date-time": "2019-11-02T19:03:31Z",
    "timestamp": 1572721411000
  },
  "deposited": {
    "date-parts": [
      [
        2020,
        11,
        1
      ]
    ],
    "date-time": "2020-11-01T00:53:44Z",
    "timestamp": 1604192024000
  },
  "funder": [
    {
      "DOI": "10.13039/501100004359",
      "award": [
        "2016-01153",
        "2016-01154"
      ],
      "doi-asserted-by": "publisher",
      "name": "Vetenskapsrådet"
    },
    {
      "DOI": "10.13039/501100007601",
      "award": [
        "668353"
      ],
      "doi-asserted-by": "publisher",
      "name": "Horizon 2020"
    }
  ],
  "indexed": {
    "date-parts": [
      [
        2024,
        4,
        10
      ]
    ],
    "date-time": "2024-04-10T05:15:36Z",
    "timestamp": 1712726136683
  },
  "is-referenced-by-count": 75,
  "issn-type": [
    {
      "type": "print",
      "value": "0340-6717"
    },
    {
      "type": "electronic",
      "value": "1432-1203"
    }
  ],
  "issue": "11-12",
  "issued": {
    "date-parts": [
      [
        2019,
        11,
        2
      ]
    ]
  },
  "journal-issue": {
    "issue": "11-12",
    "published-print": {
      "date-parts": [
        [
          2019,
          12
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2019,
            11,
            2
          ]
        ],
        "date-time": "2019-11-02T00:00:00Z",
        "timestamp": 1572652800000
      }
    },
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "vor",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2019,
            11,
            2
          ]
        ],
        "date-time": "2019-11-02T00:00:00Z",
        "timestamp": 1572652800000
      }
    }
  ],
  "link": [
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s00439-019-02081-x.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/article/10.1007/s00439-019-02081-x/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s00439-019-02081-x.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "1359-1377",
  "prefix": "10.1007",
  "published": {
    "date-parts": [
      [
        2019,
        11,
        2
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2019,
        11,
        2
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2019,
        12
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1038/nmeth0410-248",
      "author": "IA Adzhubei",
      "doi-asserted-by": "publisher",
      "first-page": "248",
      "journal-title": "Nat Methods",
      "key": "2081_CR1",
      "unstructured": "Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, Kondrashov AS, Sunyaev SR (2010) A method and server for predicting damaging missense mutations. Nat Methods 7:248–249. \nhttps://doi.org/10.1038/nmeth0410-248",
      "volume": "7",
      "year": "2010"
    },
    {
      "DOI": "10.1016/j.jcv.2015.05.010",
      "author": "J Ampuero",
      "doi-asserted-by": "publisher",
      "first-page": "56",
      "journal-title": "J Clin Virol",
      "key": "2081_CR2",
      "unstructured": "Ampuero J, Del Campo JA, Rojas L, Calleja JL, Cabezas J, Lens S, Crespo J, Forns X, Andrade RJ, Fernández I, Buti M, Millán R, Romero-Gómez M (2015) Role of ITPA and SLC28A2 genes in the prediction of anaemia associated with protease inhibitor plus ribavirin and peginterferon in hepatitis C treatment. J Clin Virol 68:56–60. \nhttps://doi.org/10.1016/j.jcv.2015.05.010",
      "volume": "68",
      "year": "2015"
    },
    {
      "DOI": "10.1016/j.mam.2012.07.010",
      "author": "CM Anderson",
      "doi-asserted-by": "publisher",
      "first-page": "516",
      "journal-title": "Mol Aspects Med",
      "key": "2081_CR3",
      "unstructured": "Anderson CM, Stahl A (2013) SLC27 fatty acid transport proteins. Mol Aspects Med 34:516–528. \nhttps://doi.org/10.1016/j.mam.2012.07.010",
      "volume": "34",
      "year": "2013"
    },
    {
      "DOI": "10.2217/pgs.12.150",
      "author": "P Bohanec Grabar",
      "doi-asserted-by": "publisher",
      "first-page": "1583",
      "journal-title": "Pharmacogenomics",
      "key": "2081_CR4",
      "unstructured": "Bohanec Grabar P, Leandro-García LJ, Inglada-Pérez L, Logar D, Rodríguez-Antona C, Dolzan V (2012) Genetic variation in the SLC19A1 gene and methotrexate toxicity in rheumatoid arthritis patients. Pharmacogenomics 13:1583–1594. \nhttps://doi.org/10.2217/pgs.12.150",
      "volume": "13",
      "year": "2012"
    },
    {
      "DOI": "10.1080/15257770.2016.1210805",
      "author": "RC Boswell-Casteel",
      "doi-asserted-by": "publisher",
      "first-page": "7",
      "journal-title": "Nucleosides Nucleotides Nucleic Acids",
      "key": "2081_CR5",
      "unstructured": "Boswell-Casteel RC, Hays FA (2017) Equilibrative nucleoside transporters—a review. Nucleosides Nucleotides Nucleic Acids 36:7–30. \nhttps://doi.org/10.1080/15257770.2016.1210805",
      "volume": "36",
      "year": "2017"
    },
    {
      "DOI": "10.1038/nrg3555",
      "author": "KM Boycott",
      "doi-asserted-by": "publisher",
      "first-page": "681",
      "journal-title": "Nat Rev Genet",
      "key": "2081_CR6",
      "unstructured": "Boycott KM, Vanstone MR, Bulman DE, MacKenzie AE (2013) Rare-disease genetics in the era of next-generation sequencing: discovery to translation. Nat Rev Genet 14:681–691. \nhttps://doi.org/10.1038/nrg3555",
      "volume": "14",
      "year": "2013"
    },
    {
      "DOI": "10.1038/sj.bjc.6605587",
      "author": "J Bray",
      "doi-asserted-by": "publisher",
      "first-page": "1003",
      "journal-title": "Br J Cancer",
      "key": "2081_CR7",
      "unstructured": "Bray J, Sludden J, Griffin MJ, Cole M, Verrill M, Jamieson D, Boddy AV (2010) Influence of pharmacogenetics on response and toxicity in breast cancer patients treated with doxorubicin and cyclophosphamide. Br J Cancer 102:1003–1009. \nhttps://doi.org/10.1038/sj.bjc.6605587",
      "volume": "102",
      "year": "2010"
    },
    {
      "DOI": "10.1002/cpt.350",
      "author": "WS Bush",
      "doi-asserted-by": "publisher",
      "first-page": "160",
      "journal-title": "Clin Pharmacol Ther",
      "key": "2081_CR8",
      "unstructured": "Bush WS, Crosslin DR, Owusu-Obeng A, Wallace J, Almoguera B, Basford MA, Bielinski SJ, Carrell DS, Connolly JJ, Crawford D, Doheny KF, Gallego CJ, Gordon AS, Keating B, Kirby J, Kitchner T, Manzi S, Mejia AR, Pan V, Perry CL, Peterson JF, Prows CA, Ralston J, Scott SA, Scrol A, Smith M, Stallings SC, Veldhuizen T, Wolf W, Volpi S, Wiley K, Li R, Manolio T, Bottinger E, Brilliant MH, Carey D, Chisholm RL, Chute CG, Haines JL, Hakonarson H, Harley JB, Holm IA, Kullo IJ, Jarvik GP, Larson EB, McCarty CA, Williams MS, Denny JC, Rasmussen-Torvik LJ, Roden DM, Ritchie MD (2016) Genetic variation among 82 pharmacogenes: the PGRNseq data from the eMERGE network. Clin Pharmacol Ther 100:160–169. \nhttps://doi.org/10.1002/cpt.350",
      "volume": "100",
      "year": "2016"
    },
    {
      "DOI": "10.1038/s41598-017-17731-1",
      "author": "L-L Cai",
      "doi-asserted-by": "publisher",
      "first-page": "17379",
      "journal-title": "Sci Rep",
      "key": "2081_CR9",
      "unstructured": "Cai L-L, Huang WQ, Su Z-Y, Ye H-M, Wang L-S, Wu Y, Zhang Z-Y, Zhang W, Tzeng C-M (2017) Identification of two novel genes SLC15A2 and SLCO1B3 associated with maintenance dose variability of warfarin in a Chinese population. Sci Rep 7:17379. \nhttps://doi.org/10.1038/s41598-017-17731-1",
      "volume": "7",
      "year": "2017"
    },
    {
      "DOI": "10.1146/annurev.genom.9.081307.164258",
      "author": "MC Campbell",
      "doi-asserted-by": "publisher",
      "first-page": "403",
      "journal-title": "Annu Rev Genomics Hum Genet",
      "key": "2081_CR10",
      "unstructured": "Campbell MC, Tishkoff SA (2008) African genetic diversity: implications for human demographic history, modern human origins, and complex disease mapping. Annu Rev Genomics Hum Genet 9:403–433. \nhttps://doi.org/10.1146/annurev.genom.9.081307.164258",
      "volume": "9",
      "year": "2008"
    },
    {
      "DOI": "10.1016/j.phrs.2018.02.005",
      "author": "S Cargnin",
      "doi-asserted-by": "publisher",
      "first-page": "244",
      "journal-title": "Pharmacol Res",
      "key": "2081_CR11",
      "unstructured": "Cargnin S, Ravegnini G, Soverini S, Angelini S, Terrazzino S (2018) Impact of SLC22A1 and CYP3A5 genotypes on imatinib response in chronic myeloid leukemia: a systematic review and meta-analysis. Pharmacol Res 131:244–254. \nhttps://doi.org/10.1016/j.phrs.2018.02.005",
      "volume": "131",
      "year": "2018"
    },
    {
      "DOI": "10.1186/1471-2164-14-S3-S3",
      "author": "H Carter",
      "doi-asserted-by": "publisher",
      "first-page": "S3",
      "issue": "Suppl 3",
      "journal-title": "BMC Genomics",
      "key": "2081_CR12",
      "unstructured": "Carter H, Douville C, Stenson PD, Cooper DN, Karchin R (2013) Identifying Mendelian disease genes with the variant effect scoring tool. BMC Genomics 14(Suppl 3):S3. \nhttps://doi.org/10.1186/1471-2164-14-S3-S3",
      "volume": "14",
      "year": "2013"
    },
    {
      "DOI": "10.1016/j.cell.2015.07.022",
      "author": "A César-Razquin",
      "doi-asserted-by": "publisher",
      "first-page": "478",
      "journal-title": "Cell",
      "key": "2081_CR13",
      "unstructured": "César-Razquin A, Snijder B, Frappier-Brinton T, Isserlin R, Gyimesi G, Bai X, Reithmeier RA, Hepworth D, Hediger MA, Edwards AM, Superti-Furga G (2015) A call for systematic research on solute carriers. Cell 162:478–487. \nhttps://doi.org/10.1016/j.cell.2015.07.022",
      "volume": "162",
      "year": "2015"
    },
    {
      "DOI": "10.1124/jpet.110.170159",
      "author": "L Chen",
      "doi-asserted-by": "publisher",
      "first-page": "42",
      "journal-title": "J Pharmacol Exp Ther",
      "key": "2081_CR14",
      "unstructured": "Chen L, Takizawa M, Chen E, Schlessinger A, Segenthelar J, Choi JH, Sali A, Kubo M, Nakamura S, Iwamoto Y, Iwasaki N, Giacomini KM (2010) Genetic polymorphisms in organic cation transporter 1 (OCT1) in Chinese and Japanese populations exhibit altered function. J Pharmacol Exp Ther 335:42–50. \nhttps://doi.org/10.1124/jpet.110.170159",
      "volume": "335",
      "year": "2010"
    },
    {
      "DOI": "10.1002/bdd.1783",
      "author": "M-K Choi",
      "doi-asserted-by": "publisher",
      "first-page": "170",
      "journal-title": "Biopharm Drug Dispos",
      "key": "2081_CR15",
      "unstructured": "Choi M-K, Song I-S (2012) Genetic variants of organic cation transporter 1 (OCT1) and OCT2 significantly reduce lamivudine uptake. Biopharm Drug Dispos 33:170–178. \nhttps://doi.org/10.1002/bdd.1783",
      "volume": "33",
      "year": "2012"
    },
    {
      "DOI": "10.1038/clpt.2011.165",
      "author": "J-H Choi",
      "doi-asserted-by": "publisher",
      "first-page": "674",
      "journal-title": "Clin Pharmacol Ther",
      "key": "2081_CR16",
      "unstructured": "Choi J-H, Yee SW, Ramirez AH, Morrissey KM, Jang GH, Joski PJ, Mefford JA, Hesselson SE, Schlessinger A, Jenkins G, Castro RA, Johns SJ, Stryke D, Sali A, Ferrin TE, Witte JS, Kwok P-Y, Roden DM, Wilke RA, McCarty CA, Davis RL, Giacomini KM (2011) A common 5′-UTR variant in MATE2-K is associated with poor response to metformin. Clin Pharmacol Ther 90:674–684. \nhttps://doi.org/10.1038/clpt.2011.165",
      "volume": "90",
      "year": "2011"
    },
    {
      "DOI": "10.1371/journal.pone.0046688",
      "author": "Y Choi",
      "doi-asserted-by": "publisher",
      "first-page": "e46688",
      "journal-title": "PLoS One",
      "key": "2081_CR17",
      "unstructured": "Choi Y, Sims GE, Murphy S, Miller JR, Chan AP (2012) Predicting the functional effect of amino acid substitutions and indels. PLoS One 7:e46688. \nhttps://doi.org/10.1371/journal.pone.0046688",
      "volume": "7",
      "year": "2012"
    },
    {
      "DOI": "10.1101/gr.092619.109",
      "author": "S Chun",
      "doi-asserted-by": "publisher",
      "first-page": "1553",
      "journal-title": "Genome Res",
      "key": "2081_CR18",
      "unstructured": "Chun S, Fay JC (2009) Identification of deleterious mutations within three human genomes. Genome Res 19:1553–1561. \nhttps://doi.org/10.1101/gr.092619.109",
      "volume": "19",
      "year": "2009"
    },
    {
      "DOI": "10.1038/tpj.2014.13",
      "author": "A Corrigan",
      "doi-asserted-by": "publisher",
      "first-page": "411",
      "journal-title": "Pharmacogenomics J",
      "key": "2081_CR19",
      "unstructured": "Corrigan A, Walker JL, Wickramasinghe S, Hernandez MA, Newhouse SJ, Folarin AA, Lewis CM, Sanderson JD, Spicer J, Marinaki AM (2014) Pharmacogenetics of pemetrexed combination therapy in lung cancer: pathway analysis reveals novel toxicity associations. Pharmacogenomics J 14:411–417. \nhttps://doi.org/10.1038/tpj.2014.13",
      "volume": "14",
      "year": "2014"
    },
    {
      "DOI": "10.1371/journal.pcbi.1001025",
      "author": "EV Davydov",
      "doi-asserted-by": "publisher",
      "first-page": "e1001025-13",
      "journal-title": "PLoS Comput Biol",
      "key": "2081_CR20",
      "unstructured": "Davydov EV, Goode DL, Sirota M, Cooper GM, Sidow A, Batzoglou S (2010) Identifying a High Fraction of the Human Genome to be under Selective Constraint Using GERP ++. PLoS Comput Biol 6:e1001025-13. \nhttps://doi.org/10.1371/journal.pcbi.1001025",
      "volume": "6",
      "year": "2010"
    },
    {
      "DOI": "10.1016/j.seizure.2013.07.003",
      "author": "V De Giorgis",
      "doi-asserted-by": "publisher",
      "first-page": "803",
      "journal-title": "Seizure",
      "key": "2081_CR21",
      "unstructured": "De Giorgis V, Veggiotti P (2013) GLUT1 deficiency syndrome 2013: current state of the art. Seizure 22:803–811. \nhttps://doi.org/10.1016/j.seizure.2013.07.003",
      "volume": "22",
      "year": "2013"
    },
    {
      "DOI": "10.1038/nature13306",
      "author": "D Deng",
      "doi-asserted-by": "publisher",
      "first-page": "121",
      "journal-title": "Nature",
      "key": "2081_CR22",
      "unstructured": "Deng D, Xu C, Sun P, Wu J, Yan C, Hu M, Yan N (2014) Crystal structure of the human glucose transporter GLUT1. Nature 510:121–125. \nhttps://doi.org/10.1038/nature13306",
      "volume": "510",
      "year": "2014"
    },
    {
      "DOI": "10.1038/tpj.2014.7",
      "author": "A Di Paolo",
      "doi-asserted-by": "publisher",
      "first-page": "328",
      "journal-title": "Pharmacogenomics J",
      "key": "2081_CR23",
      "unstructured": "Di Paolo A, Polillo M, Capecchi M, Cervetti G, Baratè C, Angelini S, Guerrini F, Fontanelli G, Arici R, Ciabatti E, Grassi S, Bocci G, Hrelia P, Danesi R, Petrini M, Galimberti S (2014) The c.480C \u003e G polymorphism of hOCT1 influences imatinib clearance in patients affected by chronic myeloid leukemia. Pharmacogenomics J 14:328–335. \nhttps://doi.org/10.1038/tpj.2014.7",
      "volume": "14",
      "year": "2014"
    },
    {
      "DOI": "10.1097/FPC.0b013e32834412e7",
      "author": "A Doehring",
      "doi-asserted-by": "publisher",
      "first-page": "289",
      "journal-title": "Pharmacogenet Genomics",
      "key": "2081_CR24",
      "unstructured": "Doehring A, Hofmann WP, Schlecker C, Zeuzem S, Sarrazin C, Berg T, Müller T, Herrmann E, Geisslinger G, Lötsch J (2011) Role of nucleoside transporters SLC28A2/3 and SLC29A1/2 genetics in ribavirin therapy: protection against anemia in patients with chronic hepatitis C. Pharmacogenet Genomics 21:289–296. \nhttps://doi.org/10.1097/FPC.0b013e32834412e7",
      "volume": "21",
      "year": "2011"
    },
    {
      "DOI": "10.1093/hmg/ddu733",
      "author": "C Dong",
      "doi-asserted-by": "publisher",
      "first-page": "2125",
      "journal-title": "Hum Mol Genet",
      "key": "2081_CR25",
      "unstructured": "Dong C, Wei P, Jian X, Gibbs R, Boerwinkle E, Wang K, Liu X (2015) Comparison and integration of deleteriousness prediction methods for nonsynonymous SNVs in whole exome sequencing studies. Hum Mol Genet 24:2125–2137. \nhttps://doi.org/10.1093/hmg/ddu733",
      "volume": "24",
      "year": "2015"
    },
    {
      "DOI": "10.1001/jamaoncol.2017.0502",
      "author": "BI Drögemöller",
      "doi-asserted-by": "publisher",
      "first-page": "1558",
      "journal-title": "JAMA Oncol",
      "key": "2081_CR26",
      "unstructured": "Drögemöller BI, Monzon JG, Bhavsar AP, Borrie AE, Brooks B, Wright GEB, Liu G, Renouf DJ, Kollmannsberger CK, Bedard PL, Aminkeng F, Amstutz U, Hildebrand CA, Gunaretnam EP, Critchley C, Chen Z, Brunham LR, Hayden MR, Ross CJD, Gelmon KA, Carleton BC (2017) Association between SLC16A5 genetic variation and cisplatin-induced ototoxic effects in adult patients with testicular cancer. JAMA Oncol 3:1558–1562. \nhttps://doi.org/10.1001/jamaoncol.2017.0502",
      "volume": "3",
      "year": "2017"
    },
    {
      "DOI": "10.2337/db14-1388",
      "author": "T Dujic",
      "doi-asserted-by": "publisher",
      "first-page": "1786",
      "journal-title": "Diabetes",
      "key": "2081_CR27",
      "unstructured": "Dujic T, Zhou K, Donnelly LA, Tavendale R, Palmer CNA, Pearson ER (2015) Association of organic cation transporter 1 with intolerance to metformin in type 2 diabetes: a GoDARTS study. Diabetes 64:1786–1793. \nhttps://doi.org/10.2337/db14-1388",
      "volume": "64",
      "year": "2015"
    },
    {
      "DOI": "10.1186/1750-1172-7-19",
      "author": "T Eggermann",
      "doi-asserted-by": "publisher",
      "first-page": "19",
      "journal-title": "Orphanet J Rare Dis",
      "key": "2081_CR28",
      "unstructured": "Eggermann T, Venghaus A, Zerres K (2012) Cystinuria: an inborn cause of urolithiasis. Orphanet J Rare Dis 7:19. \nhttps://doi.org/10.1186/1750-1172-7-19",
      "volume": "7",
      "year": "2012"
    },
    {
      "DOI": "10.2174/0929867324666170718101946",
      "author": "A Fernandez-Marmiesse",
      "doi-asserted-by": "publisher",
      "first-page": "404",
      "journal-title": "Curr Med Chem",
      "key": "2081_CR29",
      "unstructured": "Fernandez-Marmiesse A, Gouveia S, Couce ML (2018) NGS technologies as a turning point in rare disease research, diagnosis and treatment. Curr Med Chem 25:404–432. \nhttps://doi.org/10.2174/0929867324666170718101946",
      "volume": "25",
      "year": "2018"
    },
    {
      "DOI": "10.1016/j.febslet.2008.10.016",
      "author": "R Fredriksson",
      "doi-asserted-by": "publisher",
      "first-page": "3811",
      "journal-title": "FEBS Lett",
      "key": "2081_CR30",
      "unstructured": "Fredriksson R, Nordström KJV, Stephansson O, Hägglund MGA, Schiöth HB (2008) The solute carrier (SLC) complement of the human genome: phylogenetic classification reveals four major families. FEBS Lett 582:3811–3816. \nhttps://doi.org/10.1016/j.febslet.2008.10.016",
      "volume": "582",
      "year": "2008"
    },
    {
      "DOI": "10.1371/journal.pone.0155552",
      "author": "K Fujikura",
      "doi-asserted-by": "publisher",
      "first-page": "e0155552",
      "journal-title": "PLoS One",
      "key": "2081_CR31",
      "unstructured": "Fujikura K (2016) Global carrier rates of rare inherited disorders using population exome sequences. PLoS One 11:e0155552. \nhttps://doi.org/10.1371/journal.pone.0155552",
      "volume": "11",
      "year": "2016"
    },
    {
      "DOI": "10.1097/FPC.0000000000000172",
      "author": "K Fujikura",
      "doi-asserted-by": "publisher",
      "first-page": "584",
      "journal-title": "Pharmacogenet Genomics",
      "key": "2081_CR32",
      "unstructured": "Fujikura K, Ingelman-Sundberg M, Lauschke VM (2015) Genetic variation in the human cytochrome P450 supergene family. Pharmacogenet Genomics 25:584–594. \nhttps://doi.org/10.1097/FPC.0000000000000172",
      "volume": "25",
      "year": "2015"
    },
    {
      "DOI": "10.2217/pgs.13.94",
      "author": "T Fukuda",
      "doi-asserted-by": "publisher",
      "first-page": "1141",
      "journal-title": "Pharmacogenomics",
      "key": "2081_CR33",
      "unstructured": "Fukuda T, Chidambaran V, Mizuno T, Venkatasubramanian R, Ngamprasertwong P, Olbrecht V, Esslinger HR, Vinks AA, Sadhasivam S (2013) OCT1 genetic variants influence the pharmacokinetics of morphine in children. Pharmacogenomics 14:1141–1151. \nhttps://doi.org/10.2217/pgs.13.94",
      "volume": "14",
      "year": "2013"
    },
    {
      "DOI": "10.1038/s41598-018-37367-z",
      "author": "T Galochkina",
      "doi-asserted-by": "publisher",
      "first-page": "998",
      "journal-title": "Sci Rep",
      "key": "2081_CR34",
      "unstructured": "Galochkina T, Ng Fuk Chong M, Challali L, Abbar S, Etchebest C (2019) New insights into GluT1 mechanics during glucose transfer. Sci Rep 9:998. \nhttps://doi.org/10.1038/s41598-018-37367-z",
      "volume": "9",
      "year": "2019"
    },
    {
      "DOI": "10.1124/mol.107.040170",
      "author": "D Gorbunov",
      "doi-asserted-by": "publisher",
      "first-page": "50",
      "journal-title": "Mol Pharmacol",
      "key": "2081_CR35",
      "unstructured": "Gorbunov D, Gorboulev V, Shatskaya N, Mueller T, Bamberg E, Friedrich T, Koepsell H (2008) High-affinity cation binding to organic cation transporter 1 induces movement of helix 11 and blocks transport after mutations in a modeled interaction domain between two helices. Mol Pharmacol 73:50–61. \nhttps://doi.org/10.1124/mol.107.040170",
      "volume": "73",
      "year": "2008"
    },
    {
      "DOI": "10.1097/FPC.0000000000000202",
      "author": "AS Gordon",
      "doi-asserted-by": "publisher",
      "journal-title": "Pharmacogenet Genom",
      "key": "2081_CR36",
      "unstructured": "Gordon AS, Fulton RS, Qin X, Mardis ER, Nickerson DA, Scherer S (2016) PGRNseq: a targeted capture sequencing panel for pharmacogenetic research and implementation. Pharmacogenet Genom. \nhttps://doi.org/10.1097/FPC.0000000000000202",
      "year": "2016"
    },
    {
      "DOI": "10.1186/s12920-019-0527-2",
      "author": "M Gulilat",
      "doi-asserted-by": "publisher",
      "first-page": "81",
      "journal-title": "BMC Med Genomics",
      "key": "2081_CR37",
      "unstructured": "Gulilat M, Lamb T, Teft WA, Wang J, Dron JS, Robinson JF, Tirona RG, Hegele RA, Kim RB, Schwarz UI (2019) Targeted next generation sequencing as a tool for precision medicine. BMC Med Genomics 12:81. \nhttps://doi.org/10.1186/s12920-019-0527-2",
      "volume": "12",
      "year": "2019"
    },
    {
      "DOI": "10.1002/humu.23555",
      "author": "A Henrie",
      "doi-asserted-by": "publisher",
      "first-page": "1051",
      "journal-title": "Hum Mutat",
      "key": "2081_CR38",
      "unstructured": "Henrie A, Hemphill SE, Ruiz-Schultz N, Cushman B, DiStefano MT, Azzariti D, Harrison SM, Rehm HL, Eilbeck K (2018) ClinVar Miner: demonstrating utility of a Web-based tool for viewing and filtering ClinVar data. Hum Mutat 39:1051–1060. \nhttps://doi.org/10.1002/humu.23555",
      "volume": "39",
      "year": "2018"
    },
    {
      "DOI": "10.1093/molbev/msq350",
      "author": "PJ Höglund",
      "doi-asserted-by": "publisher",
      "first-page": "1531",
      "journal-title": "Mol Biol Evol",
      "key": "2081_CR39",
      "unstructured": "Höglund PJ, Nordström KJV, Schiöth HB, Fredriksson R (2011) The solute carrier families have a remarkably long evolutionary history with the majority of the human families present before divergence of Bilaterian species. Mol Biol Evol 28:1531–1541. \nhttps://doi.org/10.1093/molbev/msq350",
      "volume": "28",
      "year": "2011"
    },
    {
      "DOI": "10.1007/s00228-010-0882-6",
      "author": "Q Huang",
      "doi-asserted-by": "publisher",
      "first-page": "1207",
      "journal-title": "Eur J Clin Pharmacol",
      "key": "2081_CR40",
      "unstructured": "Huang Q, Yin J-Y, Dai X-P, Wu J, Chen X, Deng C-S, Yu M, Gong Z-C, Zhou H-H, Liu Z-Q (2010) Association analysis of SLC30A8 rs13266634 and rs16889462 polymorphisms with type 2 diabetes mellitus and repaglinide response in Chinese patients. Eur J Clin Pharmacol 66:1207–1215. \nhttps://doi.org/10.1007/s00228-010-0882-6",
      "volume": "66",
      "year": "2010"
    },
    {
      "DOI": "10.1371/journal.pone.0077223",
      "author": "L Huang",
      "doi-asserted-by": "publisher",
      "first-page": "e77223",
      "journal-title": "PLoS One",
      "key": "2081_CR41",
      "unstructured": "Huang L, Zhang T, Xie C, Liao X, Yu Q, Feng J, Ma H, Dai J, Li M, Chen J, Zang A, Wang Q, Ge S, Qin K, Cai J, Yuan X (2013) SLCO1B1 and SLC19A1 gene variants and irinotecan-induced rapid response and survival: a prospective multicenter pharmacogenetics study of metastatic colorectal cancer. PLoS One 8:e77223. \nhttps://doi.org/10.1371/journal.pone.0077223",
      "volume": "8",
      "year": "2013"
    },
    {
      "DOI": "10.1186/s40246-018-0157-3",
      "author": "M Ingelman-Sundberg",
      "doi-asserted-by": "publisher",
      "first-page": "26",
      "journal-title": "Human Genomics",
      "key": "2081_CR42",
      "unstructured": "Ingelman-Sundberg M, Mkrtchian S, Zhou Y, Lauschke VM (2018) Integrating rare genetic variants into pharmacogenetic drug response predictions. Human Genomics 12:26. \nhttps://doi.org/10.1186/s40246-018-0157-3",
      "volume": "12",
      "year": "2018"
    },
    {
      "DOI": "10.1200/JCO.2010.28.0792",
      "author": "DC Johnson",
      "doi-asserted-by": "publisher",
      "first-page": "797",
      "journal-title": "J Clin Oncol",
      "key": "2081_CR43",
      "unstructured": "Johnson DC, Corthals SL, Walker BA, Ross FM, Gregory WM, Dickens NJ, Lokhorst HM, Goldschmidt H, Davies FE, Durie BGM, Van Ness B, Child JA, Sonneveld P, Morgan GJ (2011) Genetic factors underlying the risk of thalidomide-related neuropathy in patients with multiple myeloma. J Clin Oncol 29:797–804. \nhttps://doi.org/10.1200/JCO.2010.28.0792",
      "volume": "29",
      "year": "2011"
    },
    {
      "DOI": "10.1124/dmd.104.001800",
      "author": "N Kaniwa",
      "doi-asserted-by": "publisher",
      "first-page": "458",
      "journal-title": "Drug Metab Dispos",
      "key": "2081_CR44",
      "unstructured": "Kaniwa N, Kurose K, Jinno H, Tanaka-Kagawa T, Saito Y, Saeki M, Sawada J-i, Tohkin M, Hasegawa R (2005) Racial variability in haplotype frequencies of UGT1A1 and glucuronidation activity of a novel single nucleotide polymorphism 686C\u003eT (P229L) found in an African–American. Drug Metab Dispos 33:458–465. \nhttps://doi.org/10.1124/dmd.104.001800",
      "volume": "33",
      "year": "2005"
    },
    {
      "DOI": "10.1038/nprot.2015.053",
      "author": "LA Kelley",
      "doi-asserted-by": "publisher",
      "first-page": "845",
      "journal-title": "Nat Protoc",
      "key": "2081_CR45",
      "unstructured": "Kelley LA, Mezulis S, Yates CM, Wass MN, Sternberg MJE (2015) The Phyre2 web portal for protein modeling, prediction and analysis. Nat Protoc 10:845–858. \nhttps://doi.org/10.1038/nprot.2015.053",
      "volume": "10",
      "year": "2015"
    },
    {
      "DOI": "10.1371/journal.pone.0016331",
      "author": "J-H Kim",
      "doi-asserted-by": "publisher",
      "first-page": "e16331",
      "journal-title": "PLoS One",
      "key": "2081_CR46",
      "unstructured": "Kim J-H, Karpyak VM, Biernacka JM, Nam HW, Lee MR, Preuss UW, Zill P, Yoon G, Colby C, Mrazek DA, Choi D-S (2011) Functional role of the polymorphic 647 T/C variant of ENT1 (SLC29A1) and its association with alcohol withdrawal seizures. PLoS One 6:e16331. \nhttps://doi.org/10.1371/journal.pone.0016331",
      "volume": "6",
      "year": "2011"
    },
    {
      "DOI": "10.1038/ng.2892",
      "author": "M Kircher",
      "doi-asserted-by": "publisher",
      "first-page": "310",
      "journal-title": "Nat Rev Drug Discov",
      "key": "2081_CR47",
      "unstructured": "Kircher M, Witten DM, Jain P, O’Roak BJ, Cooper GM, Shendure J (2014) A general framework for estimating the relative pathogenicity of human genetic variants. Nat Rev Drug Discov 46:310–315. \nhttps://doi.org/10.1038/ng.2892",
      "volume": "46",
      "year": "2014"
    },
    {
      "DOI": "10.3389/fgene.2019.00007",
      "author": "K Klein",
      "doi-asserted-by": "publisher",
      "first-page": "56",
      "journal-title": "Front Genet",
      "key": "2081_CR48",
      "unstructured": "Klein K, Tremmel R, Winter S, Fehr S, Battke F, Scheurenbrand T, Schaeffeler E, Biskup S, Schwab M, Zanger UM (2019) A new panel-based next-generation sequencing method for ADME genes reveals novel associations of common and rare variants with expression in a human liver cohort. Front Genet 10:56. \nhttps://doi.org/10.3389/fgene.2019.00007",
      "volume": "10",
      "year": "2019"
    },
    {
      "DOI": "10.1016/j.mam.2012.10.010",
      "author": "H Koepsell",
      "doi-asserted-by": "publisher",
      "first-page": "413",
      "journal-title": "Mol Aspects Med",
      "key": "2081_CR49",
      "unstructured": "Koepsell H (2013) The SLC22 family with transporters of organic cations, anions and zwitterions. Mol Aspects Med 34:413–435. \nhttps://doi.org/10.1016/j.mam.2012.10.010",
      "volume": "34",
      "year": "2013"
    },
    {
      "DOI": "10.1038/gim.2016.33",
      "author": "M Kozyra",
      "doi-asserted-by": "publisher",
      "first-page": "20",
      "journal-title": "Genet Med",
      "key": "2081_CR50",
      "unstructured": "Kozyra M, Ingelman-Sundberg M, Lauschke VM (2017) Rare genetic variants in cellular transporters, metabolic enzymes, and nuclear receptors can be important determinants of interindividual differences in drug response. Genet Med 19:20–29. \nhttps://doi.org/10.1038/gim.2016.33",
      "volume": "19",
      "year": "2017"
    },
    {
      "DOI": "10.1001/archgenpsychiatry.2009.155",
      "author": "JS Kwon",
      "doi-asserted-by": "publisher",
      "first-page": "1233",
      "journal-title": "Arch Gen Psychiatry",
      "key": "2081_CR51",
      "unstructured": "Kwon JS, Joo YH, Nam HJ, Lim M, Cho E-Y, Jung MH, Choi J-S, Kim B, Kang D-H, Oh S, Park T, Hong KS (2009) Association of the glutamate transporter gene SLC1A1 with atypical antipsychotics-induced obsessive-compulsive symptoms. Arch Gen Psychiatry 66:1233–1241. \nhttps://doi.org/10.1001/archgenpsychiatry.2009.155",
      "volume": "66",
      "year": "2009"
    },
    {
      "DOI": "10.2217/pgs.14.182",
      "author": "C Lanvers-Kaminsky",
      "doi-asserted-by": "publisher",
      "first-page": "323",
      "journal-title": "Pharmacogenomics",
      "key": "2081_CR52",
      "unstructured": "Lanvers-Kaminsky C, Sprowl JA, Malath I, Deuster D, Eveslage M, Schlatter E, Mathijssen RH, Boos J, Jürgens H, am Zehnhoff-Dinnesen AG, Sparreboom A, Ciarimboli G (2015) Human OCT2 variant c.808G\u003eT confers protection effect against cisplatin-induced ototoxicity. Pharmacogenomics 16:323–332. \nhttps://doi.org/10.2217/pgs.14.182",
      "volume": "16",
      "year": "2015"
    },
    {
      "DOI": "10.1016/j.tips.2015.10.006",
      "author": "VM Lauschke",
      "doi-asserted-by": "publisher",
      "first-page": "85",
      "journal-title": "Trends Pharmacol Sci",
      "key": "2081_CR53",
      "unstructured": "Lauschke VM, Ingelman-Sundberg M (2016) Precision medicine and rare genetic variants. Trends Pharmacol Sci 37:85–86. \nhttps://doi.org/10.1016/j.tips.2015.10.006",
      "volume": "37",
      "year": "2016"
    },
    {
      "DOI": "10.1002/cpt.976",
      "author": "VM Lauschke",
      "doi-asserted-by": "publisher",
      "first-page": "745",
      "journal-title": "Clin Pharmacol Ther",
      "key": "2081_CR54",
      "unstructured": "Lauschke VM, Ingelman-Sundberg M (2018) How to consider rare genetic variants in personalized drug therapy. Clin Pharmacol Ther 103:745–748. \nhttps://doi.org/10.1002/cpt.976",
      "volume": "103",
      "year": "2018"
    },
    {
      "DOI": "10.18632/oncotarget.3758",
      "author": "Y-S Lee",
      "doi-asserted-by": "publisher",
      "first-page": "16449",
      "journal-title": "Oncotarget",
      "key": "2081_CR55",
      "unstructured": "Lee Y-S, Kim BH, Kim BC, Shin A, Kim JS, Hong S-H, Hwang J-A, Lee JA, Nam S, Lee SH, Bhak J, Park J-W (2015) SLC15A2 genomic variation is associated with the extraordinary response of sorafenib treatment: whole-genome analysis in patients with hepatocellular carcinoma. Oncotarget 6:16449–16460. \nhttps://doi.org/10.18632/oncotarget.3758",
      "volume": "6",
      "year": "2015"
    },
    {
      "DOI": "10.1038/nature19057",
      "author": "M Lek",
      "doi-asserted-by": "publisher",
      "first-page": "285",
      "journal-title": "Nature",
      "key": "2081_CR56",
      "unstructured": "Lek M, Karczewski KJ, Minikel EV, Samocha KE, Banks E, Fennell T, O’Donnell-Luria AH, Ware JS, Hill AJ, Cummings BB, Tukiainen T, Birnbaum DP, Kosmicki JA, Duncan LE, Estrada K, Zhao F, Zou J, Pierce-Hoffman E, Berghout J, Cooper DN, Deflaux N, DePristo M, Do R, Flannick J, Fromer M, Gauthier L, Goldstein J, Gupta N, Howrigan D, Kiezun A, Kurki MI, Moonshine AL, Natarajan P, Orozco L, Peloso GM, Poplin R, Rivas MA, Ruano-Rubio V, Rose SA, Ruderfer DM, Shakir K, Stenson PD, Stevens C, Thomas BP, Tiao G, Tusie-Luna MT, Weisburd B, Won H-H, Yu D, Altshuler DM, Ardissino D, Boehnke M, Danesh J, Donnelly S, Elosua R, Florez JC, Gabriel SB, Getz G, Glatt SJ, Hultman CM, Kathiresan S, Laakso M, McCarroll S, McCarthy MI, McGovern D, McPherson R, Neale BM, Palotie A, Purcell SM, Saleheen D, Scharf JM, Sklar P, Sullivan PF, Tuomilehto J, Tsuang MT, Watkins HC, Wilson JG, Daly MJ, MacArthur DG, Consortium EA (2016) Analysis of protein-coding genetic variation in 60,706 humans. Nature 536:285–291. \nhttps://doi.org/10.1038/nature19057",
      "volume": "536",
      "year": "2016"
    },
    {
      "DOI": "10.1093/nar/gky678",
      "author": "J Li",
      "doi-asserted-by": "publisher",
      "first-page": "7793",
      "journal-title": "Nucleic Acids Res",
      "key": "2081_CR57",
      "unstructured": "Li J, Zhao T, Zhang Y, Zhang K, Shi L, Chen Y, Wang X, Sun Z (2018) Performance evaluation of pathogenicity-computation methods for missense variants. Nucleic Acids Res 46:7793–7804. \nhttps://doi.org/10.1093/nar/gky678",
      "volume": "46",
      "year": "2018"
    },
    {
      "DOI": "10.2217/pgs.13.244",
      "author": "A Lima",
      "doi-asserted-by": "publisher",
      "first-page": "807",
      "journal-title": "Pharmacogenomics",
      "key": "2081_CR58",
      "unstructured": "Lima A, Bernardes M, Sousa H, Azevedo R, Costa L, Ventura F, Seabra V, Medeiros R (2014) SLC19A1 80G allele as a biomarker of methotrexate-related gastrointestinal toxicity in Portuguese rheumatoid arthritis patients. Pharmacogenomics 15:807–820. \nhttps://doi.org/10.2217/pgs.13.244",
      "volume": "15",
      "year": "2014"
    },
    {
      "DOI": "10.1038/nrd4626",
      "author": "L Lin",
      "doi-asserted-by": "publisher",
      "first-page": "543",
      "journal-title": "Nat Rev Drug Discovery",
      "key": "2081_CR59",
      "unstructured": "Lin L, Yee SW, Kim RB, Giacomini KM (2015) SLC transporters as therapeutic targets: emerging opportunities. Nat Rev Drug Discovery 14:543–560. \nhttps://doi.org/10.1038/nrd4626",
      "volume": "14",
      "year": "2015"
    },
    {
      "DOI": "10.1007/s10038-005-0262-8",
      "author": "YB Lu",
      "doi-asserted-by": "publisher",
      "first-page": "338",
      "journal-title": "J Hum Genet",
      "key": "2081_CR60",
      "unstructured": "Lu YB, Kobayashi K, Ushikai M, Tabata A, Iijima M, Li MX, Lei L, Kawabe K, Taura S, Yang Y, Liu T-T, Chiang S-H, Hsiao K-J, Lau Y-L, Tsui L-C, Lee DH, Saheki T (2005) Frequency and distribution in East Asia of 12 mutations identified in the SLC25A13 gene of Japanese patients with citrin deficiency. J Hum Genet 50:338–346. \nhttps://doi.org/10.1007/s10038-005-0262-8",
      "volume": "50",
      "year": "2005"
    },
    {
      "DOI": "10.1093/bioinformatics/btv402",
      "author": "MJ Machiela",
      "doi-asserted-by": "publisher",
      "first-page": "3555",
      "journal-title": "Bioinformatics",
      "key": "2081_CR61",
      "unstructured": "Machiela MJ, Chanock SJ (2015) LDlink: a web-based application for exploring population-specific haplotype structure and linking correlated alleles of possible functional variants. Bioinformatics 31:3555–3557. \nhttps://doi.org/10.1093/bioinformatics/btv402",
      "volume": "31",
      "year": "2015"
    },
    {
      "DOI": "10.1007/s12041-018-0978-9",
      "author": "SM Makhtar",
      "doi-asserted-by": "publisher",
      "first-page": "835",
      "journal-title": "Journal of Genetics",
      "key": "2081_CR62",
      "unstructured": "Makhtar SM, Husin A, Baba AA, Ankathil R (2018) Genetic variations in influx transporter gene SLC22A1 are associated with clinical responses to imatinib mesylate among Malaysian chronic myeloid leukaemia patients. Journal of Genetics 97:835–842. \nhttps://doi.org/10.1007/s12041-018-0978-9",
      "volume": "97",
      "year": "2018"
    },
    {
      "DOI": "10.1038/nature08494",
      "author": "TA Manolio",
      "doi-asserted-by": "publisher",
      "first-page": "747",
      "journal-title": "Nature",
      "key": "2081_CR63",
      "unstructured": "Manolio TA, Collins FS, Cox NJ, Goldstein DB, Hindorff LA, Hunter DJ, McCarthy MI, Ramos EM, Cardon LR, Chakravarti A, Cho JH, Guttmacher AE, Kong A, Kruglyak L, Mardis E, Rotimi CN, Slatkin M, Valle D, Whittemore AS, Boehnke M, Clark AG, Eichler EE, Gibson G, Haines JL, Mackay TFC, McCarroll SA, Visscher PM (2009) Finding the missing heritability of complex diseases. Nature 461:747–753. \nhttps://doi.org/10.1038/nature08494",
      "volume": "461",
      "year": "2009"
    },
    {
      "DOI": "10.1097/FPC.0b013e32833f2cd0",
      "author": "H Moncrieffe",
      "doi-asserted-by": "publisher",
      "first-page": "665",
      "journal-title": "Pharmacogenet Genomics",
      "key": "2081_CR64",
      "unstructured": "Moncrieffe H, Hinks A, Ursu S, Kassoumeri L, Etheridge A, Hubank M, Martin P, Weiler T, Glass DN, Thompson SD, Thomson W, Wedderburn LR (2010) Generation of novel pharmacogenomic candidates in response to methotrexate in juvenile idiopathic arthritis: correlation between gene expression and genotype. Pharmacogenet Genomics 20:665–676. \nhttps://doi.org/10.1097/FPC.0b013e32833f2cd0",
      "volume": "20",
      "year": "2010"
    },
    {
      "DOI": "10.1016/j.mam.2012.07.001",
      "author": "M Mueckler",
      "doi-asserted-by": "publisher",
      "first-page": "121",
      "journal-title": "Mol Aspects Med",
      "key": "2081_CR65",
      "unstructured": "Mueckler M, Thorens B (2013) The SLC2 (GLUT) family of membrane transporters. Mol Aspects Med 34:121–138. \nhttps://doi.org/10.1016/j.mam.2012.07.001",
      "volume": "34",
      "year": "2013"
    },
    {
      "DOI": "10.1101/gr.176601",
      "author": "PC Ng",
      "doi-asserted-by": "publisher",
      "first-page": "863",
      "journal-title": "Genome Res",
      "key": "2081_CR66",
      "unstructured": "Ng PC, Henikoff S (2001) Predicting deleterious amino acid substitutions. Genome Res 11:863–874. \nhttps://doi.org/10.1101/gr.176601",
      "volume": "11",
      "year": "2001"
    },
    {
      "DOI": "10.1186/s12864-019-5865-0",
      "author": "T Orioli",
      "doi-asserted-by": "publisher",
      "first-page": "547",
      "journal-title": "BMC Genomics",
      "key": "2081_CR67",
      "unstructured": "Orioli T, Vihinen M (2019) Benchmarking subcellular localization and variant tolerance predictors on membrane proteins. BMC Genomics 20:547. \nhttps://doi.org/10.1186/s12864-019-5865-0",
      "volume": "20",
      "year": "2019"
    },
    {
      "DOI": "10.1371/journal.pone.0125361",
      "author": "M-S Park",
      "doi-asserted-by": "publisher",
      "first-page": "e0125361",
      "journal-title": "PLoS One",
      "key": "2081_CR68",
      "unstructured": "Park M-S (2015) Molecular dynamics simulations of the human glucose transporter GLUT1. PLoS One 10:e0125361. \nhttps://doi.org/10.1371/journal.pone.0125361",
      "volume": "10",
      "year": "2015"
    },
    {
      "DOI": "10.1136/jmg.40.4.242",
      "author": "HJ Park",
      "doi-asserted-by": "publisher",
      "first-page": "242",
      "journal-title": "J Med Genet",
      "key": "2081_CR69",
      "unstructured": "Park HJ, Shaukat S, Liu X-Z, Hahn SH, Naz S, Ghosh M, Kim H-N, Moon S-K, Abe S, Tukamoto K, Riazuddin S, Kabra M, Erdenetungalag R, Radnaabazar J, Khan S, Pandya A, Usami S-I, Nance WE, Wilcox ER, Griffith AJ (2003) Origins and frequencies of SLC26A4 (PDS) mutations in east and south Asians: global implications for the epidemiology of deafness. J Med Genet 40:242–248. \nhttps://doi.org/10.1136/jmg.40.4.242",
      "volume": "40",
      "year": "2003"
    },
    {
      "DOI": "10.1038/nature12042",
      "author": "BP Pedersen",
      "doi-asserted-by": "publisher",
      "first-page": "533",
      "journal-title": "Nature",
      "key": "2081_CR70",
      "unstructured": "Pedersen BP, Kumar H, Waight AB, Risenmay AJ, Roe-Zurz Z, Chau BH, Schlessinger A, Bonomi M, Harries W, Sali A, Johri AK, Stroud RM (2013) Crystal structure of a eukaryotic phosphate transporter. Nature 496:533–536. \nhttps://doi.org/10.1038/nature12042",
      "volume": "496",
      "year": "2013"
    },
    {
      "DOI": "10.1016/j.phrs.2017.03.021",
      "author": "M Pellicer",
      "doi-asserted-by": "publisher",
      "first-page": "133",
      "journal-title": "Pharmacol Res",
      "key": "2081_CR71",
      "unstructured": "Pellicer M, García-González X, García MI, Robles L, Grávalos C, García-Alfonso P, Pachón V, Longo F, Martínez V, Blanco C, Iglesias I, Sanjurjo M, López-Fernández LA (2017) Identification of new SNPs associated with severe toxicity to capecitabine. Pharmacol Res 120:133–137. \nhttps://doi.org/10.1016/j.phrs.2017.03.021",
      "volume": "120",
      "year": "2017"
    },
    {
      "DOI": "10.1124/mol.104.008839",
      "author": "C Popp",
      "doi-asserted-by": "publisher",
      "first-page": "1600",
      "journal-title": "Mol Pharmacol",
      "key": "2081_CR72",
      "unstructured": "Popp C, Gorboulev V, Müller TD, Gorbunov D, Shatskaya N, Koepsell H (2005) Amino acids critical for substrate affinity of rat organic cation transporter 1 line the substrate binding region in a model derived from the tertiary structure of lactose permease. Mol Pharmacol 67:1600–1611. \nhttps://doi.org/10.1124/mol.104.008839",
      "volume": "67",
      "year": "2005"
    },
    {
      "author": "E Pras",
      "first-page": "1297",
      "journal-title": "Am J Hum Genet",
      "key": "2081_CR73",
      "unstructured": "Pras E, Raben N, Golomb E, Arber N, Aksentijevich I, Schapiro JM, Harel D, Katz G, Liberman U, Pras M (1995) Mutations in the SLC3A1 transporter gene in cystinuria. Am J Hum Genet 56:1297–1303",
      "volume": "56",
      "year": "1995"
    },
    {
      "DOI": "10.1038/tpj.2017.40",
      "author": "H-B Qiu",
      "doi-asserted-by": "publisher",
      "first-page": "460",
      "journal-title": "Pharmacogenomics J",
      "key": "2081_CR74",
      "unstructured": "Qiu H-B, Zhuang W, Wu T, Xin S, Lin C-Z, Ruan H-L, Zhu X, Huang M, Li J-L, Hou X-Y, Zhou Z-W, Wang XD (2018) Imatinib-induced ophthalmological side-effects in GIST patients are associated with the variations of EGFR, SLC22A1, SLC22A5 and ABCB1. Pharmacogenomics J 18:460–466. \nhttps://doi.org/10.1038/tpj.2017.40",
      "volume": "18",
      "year": "2018"
    },
    {
      "DOI": "10.1093/bioinformatics/btu703",
      "author": "D Quang",
      "doi-asserted-by": "publisher",
      "first-page": "761",
      "journal-title": "Bioinformatics",
      "key": "2081_CR75",
      "unstructured": "Quang D, Chen Y, Xie X (2015) DANN: a deep learning approach for annotating the pathogenicity of genetic variants. Bioinformatics 31:761–763. \nhttps://doi.org/10.1093/bioinformatics/btu703",
      "volume": "31",
      "year": "2015"
    },
    {
      "DOI": "10.1016/j.jhep.2012.11.027",
      "author": "M Rau",
      "doi-asserted-by": "publisher",
      "first-page": "669",
      "journal-title": "J Hepatol",
      "key": "2081_CR76",
      "unstructured": "Rau M, Stickel F, Russmann S, Manser CN, Becker PP, Weisskopf M, Schmitt J, Dill MT, Dufour J-F, Moradpour D, Semela D, Müllhaupt B, Geier A, (SCCS) SHCCSG (2013) Impact of genetic SLC28 transporter and ITPA variants on ribavirin serum level, hemoglobin drop and therapeutic response in patients with HCV infection. J Hepatol 58:669–675. \nhttps://doi.org/10.1016/j.jhep.2012.11.027",
      "volume": "58",
      "year": "2013"
    },
    {
      "DOI": "10.1093/nar/gkr407",
      "author": "B Reva",
      "doi-asserted-by": "publisher",
      "first-page": "e118",
      "journal-title": "Nucleic Acids Res",
      "key": "2081_CR77",
      "unstructured": "Reva B, Antipin Y, Sander C (2011) Predicting the functional impact of protein mutations: application to cancer genomics. Nucleic Acids Res 39:e118. \nhttps://doi.org/10.1093/nar/gkr407",
      "volume": "39",
      "year": "2011"
    },
    {
      "DOI": "10.1016/j.mam.2012.10.008",
      "author": "MF Romero",
      "doi-asserted-by": "publisher",
      "first-page": "159",
      "journal-title": "Mol Aspects Med",
      "key": "2081_CR78",
      "unstructured": "Romero MF, Chen A-P, Parker MD, Boron WF (2013) The SLC4 family of bicarbonate (HCO3\n−) transporters. Mol Aspects Med 34:159–182. \nhttps://doi.org/10.1016/j.mam.2012.10.008",
      "volume": "34",
      "year": "2013"
    },
    {
      "DOI": "10.1515/dmpt-2015-0019",
      "author": "Y Salinas-Delgado",
      "doi-asserted-by": "publisher",
      "first-page": "211",
      "journal-title": "Drug Metab Personal Ther",
      "key": "2081_CR79",
      "unstructured": "Salinas-Delgado Y, Galaviz-Hernández C, Toral RG, Ávila Rejón CA, Reyes-Lopez MA, Martínez AR, Martínez-Aguilar G, Sosa-Macías M (2015) The D543N polymorphism of the SLC11A1/NRAMP1 gene is associated with treatment failure in male patients with pulmonary tuberculosis. Drug Metab Personal Ther 30:211–214. \nhttps://doi.org/10.1515/dmpt-2015-0019",
      "volume": "30",
      "year": "2015"
    },
    {
      "DOI": "10.1074/jbc.M111.226894",
      "author": "A Salin-Cantegrel",
      "doi-asserted-by": "publisher",
      "first-page": "28456",
      "journal-title": "J Biol Chem",
      "key": "2081_CR80",
      "unstructured": "Salin-Cantegrel A, Rivière J-B, Shekarabi M, Rasheed S, Dacal S, Laganière J, Gaudet R, Rochefort D, Lesca G, Gaspar C, Dion PA, Lapointe J-Y, Rouleau GA (2011) Transit defect of potassium-chloride Co-transporter 3 is a major pathogenic mechanism in hereditary motor and sensory neuropathy with agenesis of the corpus callosum. J Biol Chem 286:28456–28465. \nhttps://doi.org/10.1074/jbc.M111.226894",
      "volume": "286",
      "year": "2011"
    },
    {
      "DOI": "10.1038/gim.2017.156",
      "author": "M Santos",
      "doi-asserted-by": "publisher",
      "first-page": "622",
      "journal-title": "Genet Med",
      "key": "2081_CR81",
      "unstructured": "Santos M, Niemi M, Hiratsuka M, Kumondai M, Ingelman-Sundberg M, Lauschke VM, Rodríguez-Antona C (2018) Novel copy-number variations in pharmacogenes contribute to interindividual differences in drug pharmacokinetics. Genet Med 20:622–629. \nhttps://doi.org/10.1038/gim.2017.156",
      "volume": "20",
      "year": "2018"
    },
    {
      "DOI": "10.1038/clpt.2013.73",
      "author": "A Schlessinger",
      "doi-asserted-by": "publisher",
      "first-page": "19",
      "journal-title": "Clin Pharmacol Ther",
      "key": "2081_CR82",
      "unstructured": "Schlessinger A, Yee SW, Sali A, Giacomini KM (2013) SLC classification: an update. Clin Pharmacol Ther 94:19–23. \nhttps://doi.org/10.1038/clpt.2013.73",
      "volume": "94",
      "year": "2013"
    },
    {
      "DOI": "10.1186/s13073-015-0172-0",
      "author": "T Seitz",
      "doi-asserted-by": "publisher",
      "first-page": "56",
      "journal-title": "Genome Med",
      "key": "2081_CR83",
      "unstructured": "Seitz T, Stalmann R, Dalila N, Chen J, Pojar S, dos Santos Pereira JN, Krätzner R, Brockmöller J, Tzvetkov MV (2015) Global genetic analyses reveal strong inter-ethnic variability in the loss of activity of the organic cation transporter OCT1. Genome Med 7:56. \nhttps://doi.org/10.1186/s13073-015-0172-0",
      "volume": "7",
      "year": "2015"
    },
    {
      "DOI": "10.1002/humu.22225",
      "author": "HA Shihab",
      "doi-asserted-by": "publisher",
      "first-page": "57",
      "journal-title": "Hum Mutat",
      "key": "2081_CR84",
      "unstructured": "Shihab HA, Gough J, Cooper DN, Stenson PD, Barker GLA, Edwards KJ, Day INM, Gaunt TR (2012) Predicting the functional, molecular, and phenotypic consequences of amino acid substitutions using hidden Markov models. Hum Mutat 34:57–65. \nhttps://doi.org/10.1002/humu.22225",
      "volume": "34",
      "year": "2012"
    },
    {
      "DOI": "10.1093/bioinformatics/btv009",
      "author": "HA Shihab",
      "doi-asserted-by": "publisher",
      "first-page": "1536",
      "journal-title": "Bioinformatics",
      "key": "2081_CR85",
      "unstructured": "Shihab HA, Rogers MF, Gough J, Mort M, Cooper DN, Day INM, Gaunt TR, Campbell C (2015) An integrative approach to predicting the functional effects of non-coding and coding sequence variation. Bioinformatics 31:1536–1543. \nhttps://doi.org/10.1093/bioinformatics/btv009",
      "volume": "31",
      "year": "2015"
    },
    {
      "DOI": "10.1371/journal.pone.0111887",
      "author": "S-W Shin",
      "doi-asserted-by": "publisher",
      "first-page": "e111887",
      "journal-title": "PLoS One",
      "key": "2081_CR86",
      "unstructured": "Shin S-W, Park BL, Chang H, Park JS, Bae D-J, Song H-J, Choi IS, Kim M-K, Park H-S, Kim LH, Namgoong S, Kim JO, Shin HD, Park CS (2014) Exonic variants associated with development of aspirin exacerbated respiratory diseases. PLoS One 9:e111887. \nhttps://doi.org/10.1371/journal.pone.0111887",
      "volume": "9",
      "year": "2014"
    },
    {
      "DOI": "10.1073/pnas.0730858100",
      "author": "Y Shu",
      "doi-asserted-by": "publisher",
      "first-page": "5902",
      "journal-title": "Proc Natl Acad Sci",
      "key": "2081_CR87",
      "unstructured": "Shu Y, Leabman MK, Feng B, Mangravite LM, Huang CC, Stryke D, Kawamoto M, Johns SJ, DeYoung J, Carlson E, Ferrin TE, Herskowitz I, Giacomini KM, Investigators POMT (2003) Evolutionary conservation predicts function of variants of the human organic cation transporter, OCT1. Proc Natl Acad Sci 100:5902–5907. \nhttps://doi.org/10.1073/pnas.0730858100",
      "volume": "100",
      "year": "2003"
    },
    {
      "DOI": "10.1172/JCI30558",
      "author": "Y Shu",
      "doi-asserted-by": "publisher",
      "first-page": "1422",
      "journal-title": "J Clin Investig",
      "key": "2081_CR88",
      "unstructured": "Shu Y, Sheardown SA, Brown C, Owen RP, Zhang S, Castro RA, Ianculescu AG, Yue L, Lo JC, Burchard EG, Brett CM, Giacomini KM (2007) Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action. J Clin Investig 117:1422–1431. \nhttps://doi.org/10.1172/JCI30558",
      "volume": "117",
      "year": "2007"
    },
    {
      "DOI": "10.1038/clpt.2008.61",
      "author": "IS Song",
      "doi-asserted-by": "publisher",
      "first-page": "559",
      "journal-title": "Clin Pharmacol Ther",
      "key": "2081_CR89",
      "unstructured": "Song IS, Shin HJ, Shim EJ, Jung IS, Kim WY, Shon JH, Shin JG (2008) Genetic variants of the organic cation transporter 2 influence the disposition of metformin. Clin Pharmacol Ther 84:559–562. \nhttps://doi.org/10.1038/clpt.2008.61",
      "volume": "84",
      "year": "2008"
    },
    {
      "DOI": "10.1016/j.lungcan.2008.04.010",
      "author": "RA Soo",
      "doi-asserted-by": "publisher",
      "first-page": "121",
      "journal-title": "Lung Cancer",
      "key": "2081_CR90",
      "unstructured": "Soo RA, Wang LZ, Ng SS, Chong PY, Yong WP, Lee SC, Liu JJ, Choo TB, Tham LS, Lee HS, Goh BC, Soong R (2009) Distribution of gemcitabine pathway genotypes in ethnic Asians and their association with outcome in non-small cell lung cancer patients. Lung Cancer 63:121–127. \nhttps://doi.org/10.1016/j.lungcan.2008.04.010",
      "volume": "63",
      "year": "2009"
    },
    {
      "DOI": "10.1038/clpt.2012.210",
      "author": "SL Stocker",
      "doi-asserted-by": "publisher",
      "first-page": "186",
      "journal-title": "Clin Pharmacol Ther",
      "key": "2081_CR91",
      "unstructured": "Stocker SL, Morrissey KM, Yee SW, Castro RA, Xu L, Dahlin A, Ramirez AH, Roden DM, Wilke RA, McCarty CA, Davis RL, Brett CM, Giacomini KM (2013) The effect of novel promoter variants in MATE1 and MATE2 on the pharmacokinetics and pharmacodynamics of metformin. Clin Pharmacol Ther 93:186–194. \nhttps://doi.org/10.1038/clpt.2012.210",
      "volume": "93",
      "year": "2013"
    },
    {
      "DOI": "10.1002/cpt.701",
      "author": "E Sundelin",
      "doi-asserted-by": "publisher",
      "first-page": "841",
      "journal-title": "Clin Pharmacol Ther",
      "key": "2081_CR92",
      "unstructured": "Sundelin E, Gormsen LC, Jensen JB, Vendelbo MH, Jakobsen S, Munk OL, Christensen M, Brøsen K, Frøkiaer J, Jessen N (2017) Genetic polymorphisms in organic cation transporter 1 attenuates hepatic metformin exposure in humans. Clin Pharmacol Ther 102:841–848. \nhttps://doi.org/10.1002/cpt.701",
      "volume": "102",
      "year": "2017"
    },
    {
      "DOI": "10.2217/pgs.14.97",
      "author": "S Suthandiram",
      "doi-asserted-by": "publisher",
      "first-page": "1479",
      "journal-title": "Pharmacogenomics",
      "key": "2081_CR93",
      "unstructured": "Suthandiram S, Gan G-G, Zain SM, Bee P-C, Lian L-H, Chang K-M, Ong T-C, Mohamed Z (2014) Effect of polymorphisms within methotrexate pathway genes on methotrexate toxicity and plasma levels in adults with hematological malignancies. Pharmacogenomics 15:1479–1494. \nhttps://doi.org/10.2217/pgs.14.97",
      "volume": "15",
      "year": "2014"
    },
    {
      "DOI": "10.1097/FPC.0b013e3283561666",
      "author": "L Tarasova",
      "doi-asserted-by": "publisher",
      "first-page": "659",
      "journal-title": "Pharmacogenet Genomics",
      "key": "2081_CR94",
      "unstructured": "Tarasova L, Kalnina I, Geldnere K, Bumbure A, Ritenberga R, Nikitina-Zake L, Fridmanis D, Vaivade I, Pirags V, Klovins J (2012) Association of genetic variation in the organic cation transporters OCT1, OCT2 and multidrug and toxin extrusion 1 transporter protein genes with the gastrointestinal side effects and lower BMI in metformin-treated type 2 diabetes patients. Pharmacogenet Genomics 22:659–666. \nhttps://doi.org/10.1097/FPC.0b013e3283561666",
      "volume": "22",
      "year": "2012"
    },
    {
      "DOI": "10.18632/oncotarget.24148",
      "author": "K Tecza",
      "doi-asserted-by": "publisher",
      "first-page": "9114",
      "journal-title": "Oncotarget",
      "key": "2081_CR95",
      "unstructured": "Tecza K, Pamula-Pilat J, Lanuszewska J, Butkiewicz D, Grzybowska E (2018) Pharmacogenetics of toxicity of 5-fluorouracil, doxorubicin and cyclophosphamide chemotherapy in breast cancer patients. Oncotarget 9:9114–9136. \nhttps://doi.org/10.18632/oncotarget.24148",
      "volume": "9",
      "year": "2018"
    },
    {
      "DOI": "10.1371/journal.pone.0023878",
      "author": "JK Thornton",
      "doi-asserted-by": "publisher",
      "first-page": "e23878",
      "journal-title": "PLoS One",
      "key": "2081_CR96",
      "unstructured": "Thornton JK, Taylor KM, Ford D, Valentine RA (2011) Differential subcellular localization of the splice variants of the zinc transporter ZnT5 is dictated by the different C-terminal regions. PLoS One 6:e23878. \nhttps://doi.org/10.1371/journal.pone.0023878",
      "volume": "6",
      "year": "2011"
    },
    {
      "DOI": "10.1126/science.1172257",
      "author": "SA Tishkoff",
      "doi-asserted-by": "publisher",
      "first-page": "1035",
      "journal-title": "Science",
      "key": "2081_CR97",
      "unstructured": "Tishkoff SA, Reed FA, Friedlaender FR, Ehret C, Ranciaro A, Froment A, Hirbo JB, Awomoyi AA, Bodo J-M, Doumbo O, Ibrahim M, Juma AT, Kotze MJ, Lema G, Moore JH, Mortensen H, Nyambo TB, Omar SA, Powell K, Pretorius GS, Smith MW, Thera MA, Wambebe C, Weber JL, Williams SM (2009) The genetic structure and history of Africans and African Americans. Science 324:1035–1044. \nhttps://doi.org/10.1126/science.1172257",
      "volume": "324",
      "year": "2009"
    },
    {
      "DOI": "10.2217/pgs.14.21",
      "author": "JN Todd",
      "doi-asserted-by": "publisher",
      "first-page": "529",
      "journal-title": "Pharmacogenomics",
      "key": "2081_CR98",
      "unstructured": "Todd JN, Florez JC (2014) An update on the pharmacogenomics of metformin: progress, problems and potential. Pharmacogenomics 15:529–539. \nhttps://doi.org/10.2217/pgs.14.21",
      "volume": "15",
      "year": "2014"
    },
    {
      "DOI": "10.1038/6809",
      "author": "D Torrents",
      "doi-asserted-by": "publisher",
      "first-page": "293",
      "journal-title": "Nat Genet",
      "key": "2081_CR99",
      "unstructured": "Torrents D, Mykkänen J, Pineda M, Feliubadaló L, Estévez R, de Cid R, Sanjurjo P, Zorzano A, Nunes V, Huoponen K, Reinikainen A, Simell O, Savontaus ML, Aula P, Palacín M (1999) Identification of SLC7A7, encoding y + LAT-1, as the lysinuric protein intolerance gene. Nat Genet 21:293–296. \nhttps://doi.org/10.1038/6809",
      "volume": "21",
      "year": "1999"
    },
    {
      "DOI": "10.2217/pgs-2017-0095",
      "author": "MV Tzvetkov",
      "doi-asserted-by": "publisher",
      "first-page": "1515",
      "journal-title": "Pharmacogenomics",
      "key": "2081_CR100",
      "unstructured": "Tzvetkov MV (2017) OCT1 pharmacogenetics in pain management: is a clinical application within reach? Pharmacogenomics 18:1515–1523. \nhttps://doi.org/10.2217/pgs-2017-0095",
      "volume": "18",
      "year": "2017"
    },
    {
      "DOI": "10.1038/clpt.2011.56",
      "author": "MV Tzvetkov",
      "doi-asserted-by": "publisher",
      "first-page": "143",
      "journal-title": "Clin Pharmacol Ther",
      "key": "2081_CR101",
      "unstructured": "Tzvetkov MV, Saadatmand AR, Lotsch J, Tegeder I, Stingl JC, Brockmöller J (2011) Genetically polymorphic OCT1: another piece in the puzzle of the variable pharmacokinetics and pharmacodynamics of the opioidergic drug tramadol. Clin Pharmacol Ther 90:143–150. \nhttps://doi.org/10.1038/clpt.2011.56",
      "volume": "90",
      "year": "2011"
    },
    {
      "DOI": "10.1038/tpj.2010.75",
      "author": "MV Tzvetkov",
      "doi-asserted-by": "publisher",
      "first-page": "22",
      "journal-title": "Pharmacogenomics J",
      "key": "2081_CR102",
      "unstructured": "Tzvetkov MV, Saadatmand AR, Bokelmann K, Meineke I, Kaiser R, Brockmöller J (2012) Effects of OCT1 polymorphisms on the cellular uptake, plasma concentrations and efficacy of the 5-HT(3) antagonists tropisetron and ondansetron. Pharmacogenomics J 12:22–29. \nhttps://doi.org/10.1038/tpj.2010.75",
      "volume": "12",
      "year": "2012"
    },
    {
      "DOI": "10.1016/j.bcp.2013.06.019",
      "author": "MV Tzvetkov",
      "doi-asserted-by": "publisher",
      "first-page": "666",
      "journal-title": "Biochem Pharmacol",
      "key": "2081_CR103",
      "unstructured": "Tzvetkov MV, dos Santos Pereira JN, Meineke I, Saadatmand AR, Stingl JC, Brockmöller J (2013) Morphine is a substrate of the organic cation transporter OCT1 and polymorphisms in OCT1 gene affect morphine pharmacokinetics after codeine administration. Biochem Pharmacol 86:666–678. \nhttps://doi.org/10.1016/j.bcp.2013.06.019",
      "volume": "86",
      "year": "2013"
    },
    {
      "DOI": "10.1182/blood-2013-11-535864",
      "author": "MV Tzvetkov",
      "doi-asserted-by": "publisher",
      "first-page": "1427",
      "journal-title": "Blood",
      "key": "2081_CR104",
      "unstructured": "Tzvetkov MV, Seitz T, Bokelmann K, Mueller T, Brockmöller J, Koepsell H (2014) Does the haplotype Met408-Del420, which was apparently predictive for imatinib efficacy, really exist and how strongly may it affect OCT1 activity? Blood 123:1427–1429. \nhttps://doi.org/10.1182/blood-2013-11-535864",
      "volume": "123",
      "year": "2014"
    },
    {
      "DOI": "10.1038/sj.clpt.6100271",
      "author": "TJ Urban",
      "doi-asserted-by": "publisher",
      "first-page": "416",
      "journal-title": "Clin Pharmacol Ther",
      "key": "2081_CR105",
      "unstructured": "Urban TJ, Brown C, Castro RA, Shah N, Mercer R, Huang Y, Brett CM, Burchard EG, Giacomini KM (2008) Effects of genetic variation in the novel organic cation transporter, OCTN1, on the renal clearance of gabapentin. Clin Pharmacol Ther 83:416–421. \nhttps://doi.org/10.1038/sj.clpt.6100271",
      "volume": "83",
      "year": "2008"
    },
    {
      "DOI": "10.2217/pgs.15.61",
      "author": "H Visscher",
      "doi-asserted-by": "publisher",
      "first-page": "1065",
      "journal-title": "Pharmacogenomics",
      "key": "2081_CR106",
      "unstructured": "Visscher H, Rassekh SR, Sandor GS, Caron HN, van Dalen EC, Kremer LC, van der Pal HJ, Rogers PC, Rieder MJ, Carleton BC, Hayden MR, Ross CJ, consortium C (2015) Genetic variants in SLC22A17 and SLC22A7 are associated with anthracycline-induced cardiotoxicity in children. Pharmacogenomics 16:1065–1076. \nhttps://doi.org/10.2217/pgs.15.61",
      "volume": "16",
      "year": "2015"
    },
    {
      "DOI": "10.1124/mol.109.054783",
      "author": "C Volk",
      "doi-asserted-by": "publisher",
      "first-page": "275",
      "journal-title": "Mol Pharmacol",
      "key": "2081_CR107",
      "unstructured": "Volk C, Gorboulev V, Kotzsch A, Müller TD, Koepsell H (2009) Five amino acids in the innermost cavity of the substrate binding cleft of organic cation transporter 1 interact with extracellular and intracellular corticosterone. Mol Pharmacol 76:275–289. \nhttps://doi.org/10.1124/mol.109.054783",
      "volume": "76",
      "year": "2009"
    },
    {
      "DOI": "10.1038/sj.clpt.6100131",
      "author": "SV Vormfelde",
      "doi-asserted-by": "publisher",
      "first-page": "300",
      "journal-title": "Clin Pharmacol Ther",
      "key": "2081_CR108",
      "unstructured": "Vormfelde SV, Sehrt D, Toliat MR, Schirmer M, Meineke I, Tzvetkov M, Nürnberg P, Brockmöller J (2007) Genetic variation in the renal sodium transporters NKCC2, NCC, and ENaC in relation to the effects of loop diuretic drugs. Clin Pharmacol Ther 82:300–309. \nhttps://doi.org/10.1038/sj.clpt.6100131",
      "volume": "82",
      "year": "2007"
    },
    {
      "DOI": "10.1007/s12032-014-0062-0",
      "author": "S-M Wang",
      "doi-asserted-by": "publisher",
      "first-page": "62",
      "journal-title": "Med Oncol",
      "key": "2081_CR109",
      "unstructured": "Wang S-M, Sun L-L, Zeng W-X, Wu W-s, Zhang G-l (2014) Effects of a microRNA binding site polymorphism in SLC19A1 on methotrexate concentrations in Chinese children with acute lymphoblastic leukemia. Med Oncol 31:62. \nhttps://doi.org/10.1007/s12032-014-0062-0",
      "volume": "31",
      "year": "2014"
    },
    {
      "DOI": "10.1038/leu.2015.170",
      "author": "DB Watkins",
      "doi-asserted-by": "publisher",
      "first-page": "1960",
      "journal-title": "Leukemia",
      "key": "2081_CR110",
      "unstructured": "Watkins DB, Hughes TP, White DL (2015) OCT1 and imatinib transport in CML: is it clinically relevant? Leukemia 29:1960–1969. \nhttps://doi.org/10.1038/leu.2015.170",
      "volume": "29",
      "year": "2015"
    },
    {
      "DOI": "10.1002/jimd.12081",
      "author": "RA Wevers",
      "doi-asserted-by": "publisher",
      "first-page": "494",
      "journal-title": "J Inherit Metab Dis",
      "key": "2081_CR111",
      "unstructured": "Wevers RA, Christensen M, Engelke UFH, Geuer S, Coene KLM, Kwast JT, Lund AM, Vissers LELM (2019) Functional disruption of pyrimidine nucleoside transporter CNT1 results in a novel inborn error of metabolism with high excretion of uridine and cytidine. J Inherit Metab Dis 42:494–500. \nhttps://doi.org/10.1002/jimd.12081",
      "volume": "42",
      "year": "2019"
    },
    {
      "DOI": "10.1038/s41594-019-0245-7",
      "author": "NJ Wright",
      "doi-asserted-by": "publisher",
      "first-page": "599",
      "journal-title": "Nat Struct Mol Biol",
      "key": "2081_CR112",
      "unstructured": "Wright NJ, Lee S-Y (2019) Structures of human ENT1 in complex with adenosine reuptake inhibitors. Nat Struct Mol Biol 26:599–606. \nhttps://doi.org/10.1038/s41594-019-0245-7",
      "volume": "26",
      "year": "2019"
    },
    {
      "DOI": "10.1038/tpj.2016.77",
      "author": "GEB Wright",
      "doi-asserted-by": "publisher",
      "first-page": "187",
      "journal-title": "Pharmacogenomics J",
      "key": "2081_CR113",
      "unstructured": "Wright GEB, Carleton B, Hayden MR, Ross CJD (2018) The global spectrum of protein-coding pharmacogenomic diversity. Pharmacogenomics J 18:187–195. \nhttps://doi.org/10.1038/tpj.2016.77",
      "volume": "18",
      "year": "2018"
    },
    {
      "DOI": "10.1016/j.tibs.2013.01.003",
      "author": "N Yan",
      "doi-asserted-by": "publisher",
      "first-page": "151",
      "journal-title": "Trends Biochem Sci",
      "key": "2081_CR114",
      "unstructured": "Yan N (2013) Structural advances for the major facilitator superfamily (MFS) transporters. Trends Biochem Sci 38:151–159. \nhttps://doi.org/10.1016/j.tibs.2013.01.003",
      "volume": "38",
      "year": "2013"
    },
    {
      "DOI": "10.1002/jps.23581",
      "author": "SW Yee",
      "doi-asserted-by": "publisher",
      "first-page": "3451",
      "journal-title": "J Pharm Sci",
      "key": "2081_CR115",
      "unstructured": "Yee SW, Nguyen AN, Brown C, Savic RM, Zhang Y, Castro RA, Cropp CD, Choi JH, Singh D, Tahara H, Stocker SL, Huang Y, Brett CM, Giacomini KM (2013) Reduced renal clearance of cefotaxime in asians with a low-frequency polymorphism of OAT3 (SLC22A8). J Pharm Sci 102:3451–3457. \nhttps://doi.org/10.1002/jps.23581",
      "volume": "102",
      "year": "2013"
    },
    {
      "DOI": "10.1208/s12248-013-9460-z",
      "author": "H Yoon",
      "doi-asserted-by": "publisher",
      "first-page": "571",
      "journal-title": "AAPS J",
      "key": "2081_CR116",
      "unstructured": "Yoon H, Cho H-Y, Yoo H-D, Kim S-M, Lee Y-B (2013) Influences of organic cation transporter polymorphisms on the population pharmacokinetics of metformin in healthy subjects. AAPS J 15:571–580. \nhttps://doi.org/10.1208/s12248-013-9460-z",
      "volume": "15",
      "year": "2013"
    },
    {
      "DOI": "10.1016/j.phrs.2018.10.017",
      "author": "B Zhang",
      "doi-asserted-by": "publisher",
      "first-page": "550",
      "journal-title": "Pharmacol Res",
      "key": "2081_CR117",
      "unstructured": "Zhang B, Lauschke VM (2019) Genetic variability and population diversity of the human SLCO (OATP) transporter family. Pharmacol Res 139:550–559. \nhttps://doi.org/10.1016/j.phrs.2018.10.017",
      "volume": "139",
      "year": "2019"
    },
    {
      "DOI": "10.1136/jmedgenet-2018-105429",
      "author": "Y Zhou",
      "doi-asserted-by": "publisher",
      "first-page": "617",
      "journal-title": "J Med Genet",
      "key": "2081_CR118",
      "unstructured": "Zhou Y, Lauschke VM (2018) Comprehensive overview of the pharmacogenetic diversity in Ashkenazi Jews. J Med Genet 55:617–627. \nhttps://doi.org/10.1136/jmedgenet-2018-105429",
      "volume": "55",
      "year": "2018"
    },
    {
      "DOI": "10.3389/fphar.2018.01437",
      "author": "Y Zhou",
      "doi-asserted-by": "publisher",
      "first-page": "1437",
      "journal-title": "Front Pharmacol",
      "key": "2081_CR119",
      "unstructured": "Zhou Y, Fujikura K, Mkrtchian S, Lauschke VM (2018) Computational methods for the pharmacogenetic interpretation of next generation sequencing data. Front Pharmacol 9:1437. \nhttps://doi.org/10.3389/fphar.2018.01437",
      "volume": "9",
      "year": "2018"
    },
    {
      "DOI": "10.1038/s41397-018-0044-2",
      "author": "Y Zhou",
      "doi-asserted-by": "publisher",
      "first-page": "115",
      "journal-title": "Pharmacogenom J",
      "key": "2081_CR120",
      "unstructured": "Zhou Y, Mkrtchian S, Kumondai M, Hiratsuka M, Lauschke VM (2019) An optimized prediction framework to assess the functional impact of pharmacogenetic variants. Pharmacogenom J 19:115–126. \nhttps://doi.org/10.1038/s41397-018-0044-2",
      "volume": "19",
      "year": "2019"
    }
  ],
  "reference-count": 120,
  "references-count": 120,
  "resource": {
    "primary": {
      "URL": "http://link.springer.com/10.1007/s00439-019-02081-x"
    }
  },
  "score": 0,
  "short-container-title": [
    "Hum Genet"
  ],
  "source": "Crossref",
  "title": [
    "The genetic landscape of the human solute carrier (SLC) transporter superfamily"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "138"
}